Pretty encouraging report given that it assumes:
1. Xtoll takes only 4% of the market;
2. Has only a 50% chance of making the market; and
3. It seems to use a 13% discount rate for the NPV calculation, which I thought was pretty high.
Full report is available here:
www.cbio.com.au/releases/11.02.20%20Wise%20Owl%20Research%20Report.pdf
